Australia markets close in 4 hours 51 minutes

ABBV Jan 2024 200.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
48.670.00 (0.00%)
As of 02:12PM EDT. Market open.
Full screen
Previous close48.67
Open48.67
Bid44.75
Ask46.40
Strike200.00
Expiry date2024-01-19
Day's range48.67 - 48.67
Contract rangeN/A
Volume1
Open interest2
  • Motley Fool

    2 High-Yield Dividend Stocks You Won't Regret Buying Right Now

    High-yield dividend stocks can be great for managing the ongoing reset in global equity markets. Which high-yield dividend stocks are worth buying right now? Read on to find out more about these above-average passive income opportunities.

  • Zacks

    AbbVie (ABBV) Gets FDA Rejection for Parkinson's Candidate

    In the CRL, the FDA asks AbbVie (ABBV) for some extra information about the pump device used to administer the Parkinson's disease medicine, ABBV-951.

  • PR Newswire

    AbbVie Advances Upadacitinib (RINVOQ®) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

    AbbVie (NYSE: ABBV) today announced topline results from a Phase 2 study of upadacitinib (RINVOQ®, 30 mg) given alone or as combination therapy (ABBV-599) with a Bruton's Tyrosine Kinase inhibitor (elsubrutinib, 60 mg), once daily in patients with moderately to severely active systemic lupus erythematosus (SLE).1 The SLEek study met the primary endpoint of SLE Responder Index (SRI-4) and steroid dose less than or equal to 10 mg prednisone equivalent once per day at week 24 in the upadacitinib 30